EDSA NASDAQ
Edesa Biotech, Inc.
1W: -3.7%
1M: -18.9%
3M: -46.5%
YTD: +157.3%
1Y: +50.2%
3Y: -30.2%
5Y: -93.2%
$3.86
-0.15 (-3.74%)
Weekly Expected Move ±12.9%
$3
$3
$4
$4
$5
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Revenue Segmentation
By Product / Service
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$119K
+35.9% ▲
Operating Income
-$8M
-12.8% ▼
Net Income
-$7M
-16.5% ▼
EPS (Diluted)
$-1.27
+34.2% ▲
EBITDA
-$7M
-18.1% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | -100.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $119K | $118K | $183K | $186K | $119K |
| Gross Profit | -$119K | -$118K | -$183K | -$186K | -$119K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $18M | $13M | $5M | $3M | $4M |
| SG&A Expenses | $6M | $5M | $4M | $4M | $4M |
| Operating Expenses | $13M | $18M | $9M | $7M | $8M |
| Operating Income | -$24M | -$18M | -$9M | -$7M | -$8M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$13M | -$18M | -$8M | -$6M | -$7M |
| Tax Expense | $800 | $800 | $800 | $800 | $800 |
| Net Income | -$13M | -$18M | -$8M | -$6M | -$7M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-7.73 | $-8.37 | $-2.93 | $-1.93 | $-1.27 |
| EBITDA | -$13M | -$17M | -$8M | -$6M | -$7M |
| Shares Outstanding | 2M | 2M | 3M | 3M | 6M |